LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,717,000 | -42.5% | 100,000 | -40.9% | 0.08% | -43.2% |
Q2 2023 | $11,687,124 | +84.4% | 169,305 | +28.8% | 0.14% | +61.6% |
Q1 2023 | $6,338,037 | -8.6% | 131,440 | -5.4% | 0.09% | -7.5% |
Q4 2022 | $6,937,233 | +29.3% | 138,967 | +5.7% | 0.09% | +24.0% |
Q3 2022 | $5,365,000 | -91.7% | 131,500 | -88.8% | 0.08% | -92.4% |
Q2 2022 | $64,408,000 | +51.3% | 1,171,051 | 0.0% | 0.99% | +43.7% |
Q1 2022 | $42,556,000 | -38.3% | 1,171,051 | -20.8% | 0.69% | -30.0% |
Q4 2021 | $68,921,000 | -7.8% | 1,478,666 | +0.0% | 0.99% | -19.2% |
Q3 2021 | $74,758,000 | +567.0% | 1,478,594 | +441.5% | 1.22% | +484.2% |
Q2 2021 | $11,208,000 | -7.7% | 273,043 | -36.7% | 0.21% | -35.1% |
Q4 2020 | $12,149,000 | +47.2% | 431,418 | +122.5% | 0.32% | -1.5% |
Q2 2020 | $8,251,000 | – | 193,857 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |